Open access peer-reviewed chapter

Therapy for Tuberculosis: M. vaccae Inclusion into Routine Treatment

By Diana G. Dlugovitzky, Cynthia Stanford and John Stanford

Submitted: April 4th 2011Reviewed: August 11th 2011Published: February 24th 2012

DOI: 10.5772/31811

Downloaded: 1754

© 2012 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Diana G. Dlugovitzky, Cynthia Stanford and John Stanford (February 24th 2012). Therapy for Tuberculosis: M. vaccae Inclusion into Routine Treatment, Understanding Tuberculosis - Analyzing the Origin of Mycobacterium Tuberculosis Pathogenicity, Pere-Joan Cardona, IntechOpen, DOI: 10.5772/31811. Available from:

chapter statistics

1754total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Adjuvant Interferon Gamma in the Management of Multidrug - Resistant Tuberculosis

By Idrian García-García, María T Milanés-Virelles, Pedro A López-Saura, Roberto Suárez-Méndez, Magalys Valdés-Quintana, Norma Fernández-Olivera, Carmen M Valenzuela-Silva, Lidia González- Méndez, Yamilet Santos-Herrera, Gladys Abreu-Suárez and Isis Cayón-Escobar

Related Book

First chapter

Multi-Drug/Extensively Drug Resistant Tuberculosis (Mdr/Xdr-Tb): Renewed Global Battle Against Tuberculosis?

By Claude Kirimuhuzya

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us